A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
Clinical trial NCT02660424 · COMPLETED
Trial details
- NCT number
- NCT02660424
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2016-08-01
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.